2-methyl-N-[1-(3-methylpyrazin-2-yl)ethyl]-3-piperidin-1-ylpropan-1-amine

C16H28N4 — CID 102612483

IUPAC2-methyl-N-[1-(3-methylpyrazin-2-yl)ethyl]-3-piperidin-1-ylpropan-1-amine
SMILESCc1nccnc1C(C)NCC(C)CN1CCCCC1
InChIInChI=1S/C16H28N4/c1-13(12-20-9-5-4-6-10-20)11-19-15(3)16-14(2)17-7-8-18-16/h7-8,13,15,19H,4-6,9-12H2,1-3H3
InChIKeyBLMHASYIRJRPIF-UHFFFAOYSA-N
MW276.43 g/mol
LogP2.56
Rot. Bonds6

About 2-methyl-N-[1-(3-methylpyrazin-2-yl)ethyl]-3-piperidin-1-ylpropan-1-amine

2-methyl-N-[1-(3-methylpyrazin-2-yl)ethyl]-3-piperidin-1-ylpropan-1-amine (PubChem CID 102612483) has the molecular formula C16H28N4 and a molecular weight of 276.43 g/mol. Its IUPAC name is 2-methyl-N-[1-(3-methylpyrazin-2-yl)ethyl]-3-piperidin-1-ylpropan-1-amine.

Molecular Properties

Compound Name2-methyl-N-[1-(3-methylpyrazin-2-yl)ethyl]-3-piperidin-1-ylpropan-1-amine
PubChem CID102612483
Molecular FormulaC16H28N4
Molecular Weight276.43 g/mol
Exact Mass276.23
IUPAC Name2-methyl-N-[1-(3-methylpyrazin-2-yl)ethyl]-3-piperidin-1-ylpropan-1-amine
SMILESCc1nccnc1C(C)NCC(C)CN1CCCCC1
InChIInChI=1S/C16H28N4/c1-13(12-20-9-5-4-6-10-20)11-19-15(3)16-14(2)17-7-8-18-16/h7-8,13,15,19H,4-6,9-12H2,1-3H3
InChIKeyBLMHASYIRJRPIF-UHFFFAOYSA-N
XLogP2.56
TPSA41.05 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds6
Heavy Atoms20
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500276.43
LogP ≤ 52.56
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Analyze 2-methyl-N-[1-(3-methylpyrazin-2-yl)ethyl]-3-piperidin-1-ylpropan-1-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[1-(3-methylpyrazin-2-yl)ethyl]-2-pyrrolidin-1-ylpropan-1-amine
CID 114080351
N-[1-(1,3-dimethylpyrazol-4-yl)ethyl]-2-methyl-3-piperidin-1-ylpropan-1-amine
CID 65197076
2-methyl-N-[1-(4-propan-2-ylphenyl)ethyl]-3-pyrrolidin-1-ylpropan-1-amine
CID 62993891
N,N-dimethyl-1-[[1-(3-methylpyrazin-2-yl)ethylamino]methyl]cyclohexan-1-amine
CID 102612303
N-[1-(5-chlorothiophen-2-yl)ethyl]-2-methyl-3-piperidin-1-ylpropan-1-amine
CID 54906711
N-[1-(3-chlorophenyl)ethyl]-2-methyl-3-piperidin-1-ylpropan-1-amine
CID 61019279
1-[3-[1-(3-methylpyrazin-2-yl)ethylamino]propyl]piperidin-4-ol
CID 136534328
2-N-(2-methyl-3-piperidin-1-ylpropyl)propane-1,2-diamine
CID 103389396
N-[(1-ethylimidazol-2-yl)methyl]-2-methyl-3-piperidin-1-ylpropan-1-amine
CID 62350659
2-methyl-3-pyrrolidin-1-yl-N-(1-thieno[3,2-b]pyridin-6-ylethyl)propan-1-amine
CID 64830975
2-[1-(3-methylpyrazin-2-yl)ethylamino]-1-phenylethanol
CID 102612275
3,3,3-trifluoro-N-[1-(3-methylpyrazin-2-yl)ethyl]propan-1-amine
CID 102612905

Frequently Asked Questions

What is the IUPAC name of 2-methyl-N-[1-(3-methylpyrazin-2-yl)ethyl]-3-piperidin-1-ylpropan-1-amine?
The IUPAC name of 2-methyl-N-[1-(3-methylpyrazin-2-yl)ethyl]-3-piperidin-1-ylpropan-1-amine (CID 102612483) is 2-methyl-N-[1-(3-methylpyrazin-2-yl)ethyl]-3-piperidin-1-ylpropan-1-amine.
What is the SMILES notation for 2-methyl-N-[1-(3-methylpyrazin-2-yl)ethyl]-3-piperidin-1-ylpropan-1-amine?
The canonical SMILES for 2-methyl-N-[1-(3-methylpyrazin-2-yl)ethyl]-3-piperidin-1-ylpropan-1-amine is Cc1nccnc1C(C)NCC(C)CN1CCCCC1.
What is the InChIKey of 2-methyl-N-[1-(3-methylpyrazin-2-yl)ethyl]-3-piperidin-1-ylpropan-1-amine?
The InChIKey is BLMHASYIRJRPIF-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H28N4/c1-13(12-20-9-5-4-6-10-20)11-19-15(3)16-14(2)17-7-8-18-16/h7-8,13,15,19H,4-6,9-12H2,1-3H3.
What are the key properties of 2-methyl-N-[1-(3-methylpyrazin-2-yl)ethyl]-3-piperidin-1-ylpropan-1-amine?
2-methyl-N-[1-(3-methylpyrazin-2-yl)ethyl]-3-piperidin-1-ylpropan-1-amine has a molecular weight of 276.43 g/mol, XLogP of 2.56, 6 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 2-methyl-N-[1-(3-methylpyrazin-2-yl)ethyl]-3-piperidin-1-ylpropan-1-amine is sourced from PubChem (CID 102612483), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).